Abstract:The Cancer Proteome Atlas (TCPA) project collects reverse-phase protein arrays (RPPA)-based proteome datasets from nearly 8000 samples across 32 cancer types. This study aims to investigate the pan-cancer proteome signature and identify cancer subtypes of glioma, kidney cancer, and lung cancer based on TCPA data. We first visualized the tumor clustering models using t-distributed stochastic neighbour embedding (t-SNE) and biclustering heatmap. Then, three feature selection methods (pyHSICLasso, XGBoost, and Random Forest) were performed to select protein features for classifying cancer subtypes in training dataset, and the LibSVM algorithm was empolyed to test classification accuracy in the validation dataset. Clustering analysis revealed that different kinds of tumors have relatively distinct proteomic profiling based on tissue or origin. We identified 20, 10, and 20 protein features with the highest accuracies in classifying subtypes of glioma, kidney cancer, and lung cancer, respectively. The predictive abilities of the selected proteins were confirmed by receiving operating characteristic (ROC) analysis. Finally, the Bayesian network was utilized to explore the protein biomarkers that have direct causal relationships with cancer subtypes. Overall, we highlight the theoretical and technical applications of machine learning based feature selection approaches in the analysis of high-throughput biological data, particularly for cancer biomarker research. Significance: Functional proteomics is a powerful approach for characterizing cell signaling pathways and understanding their phenotypic effects on cancer development. The TCPA database provides a platform to explore and analyze TCGA pan-cancer RPPA-based protein expression. With the advent of the RPPA technology, the availability of high-throughput data in TCPA platform has made it possible to use machine learning methods to identify protein biomarkers and further differentiate subtypes of cancer based on proteomic data. In this study, we highlight the role of feature selection and Bayesian network in discovery protein biomarker for classifying cancer subtypes based on functional proteomic data. The application of machine learning methods in the analysis of high-throughput biological data, particularly for cancer biomarker researches, which have potential clinical values in developing individualized treatment strategies.

Prediction of Proteins in Cerebrospinal Fluid and Application to Glioma Biomarker Identification

Identification of Glycoproteins in Human Cerebrospinal Fluid with a Complementary Proteomic Approach

Characterization of proteome of human cerebrospinal fluid.

Deciphering Protein Secretion from the Brain to Cerebrospinal Fluid for Biomarker Discovery

Proteomic Analysis of Cerebrospinal Fluid: Toward the Identification of Biomarkers for Gliomas.

Fingerprint pattern analysis of glioma CSF protein with mass spectrometry and its clinical significance

Using feature selection and Bayesian network identify cancer subtypes based on proteomic data

Establishment of Diagnostic Model of Cerebrospinal Protein Fingerprint Pattern for Glioma and Its Clinical Application

Overall Survival Prediction for Gliomas Using a Novel Compound Approach.

Mass Spectrometric Analysis of Cerebrospinal Fluid Protein for Glioma and Its Clinical Application

A Computational Method for Prediction of Saliva-Secretory Proteins and Its Application to Identification of Head and Neck Cancer Biomarkers for Salivary Diagnosis

CFINet: Cross-Modality MRI Feature Interaction Network for Pseudoprogression Prediction of Glioblastoma.

A Novel Protein Subcellular Localization Method with CNN-XGBoost Model for Alzheimer's Disease.

A prediction model of nonclassical secreted protein based on deep learning

Predicting prognostic markers for glioma using gene co-expression network analysis.

Multimodal Data Integration Using Deep Learning Predicts Overall Survival of Patients with Glioma

Feature selection combined with top-down and bottom-up strategies for survival analysis: A case of prognostic prediction in glioblastoma

A Study of Prediction Methods for Protein Subcellular Localization

Prediction of Secreted Proteins in Human Body Fluids Using Protein Language Models and Attention

Machine-learning Based Strategy Identifies a Robust Protein Biomarker Panel for Alzheimer’s Disease in Cerebrospinal Fluid

Bioimage-Based Prediction of Protein Subcellular Location in Human Tissue with Ensemble Features and Deep Networks.